Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 1998

View Archived Issues

Disappointing results of pilot study of SDZ-PSC-833 + doxorubicin in colorectal cancer

More data reported for ADCON-P; FDA okays pivotal trial

Aphton initiates phase I/II trial of Gonadimmune in prostate cancer patients

Hybridon advances antisense drug to phase II

Another market introduction for Novartis bisphosphonate

Introgen acquires option to license Bak gene from LXR

Cortecs: year-end 1998 highlights

COHERE will track long-term effects of beta-blockade in heart failure

Nobel award brings nitric oxide into the limelight

Novel series of inhibitors of protein farnesyltransferase developed at RPR

New heteroarylsulfonamide derivatives from Knoll with broad clinical application

Stroke patients benefit from treatment with anti-ICAM-1 MAb

Bicyclic inhibitors of protein farnesyltransferase for cancer, restenosis, etc.

Roche presents series of OFQ (ORL1) receptor agonists/antagonists

Immunomodulating thalidomide analogues patented by Gruenenthal

Genset, Pharmacia & Upjohn collaborate in pharmacogenomics research

Abbott will collaborate with Nippon Shinyaku on development of incontinence Rx

U.S. patent covers protegrins and synthetic analogues such as IntraBiotics' IB-367

Fluoroquinolone derivative K-12 inhibits HIV in vitro

Demegen receives patent protection for Peptidyl MIMs in cancer indications

Antibody-based cancer product from AltaRex heading for phase I testing

Access signs more agreements for distribution of amlexanox

Successful completion of human safety trials reported for VIMRx wound-healing agent

AHP and Monsanto agree not to merge

Asahi expects approval of dysuria Rx in near future

CEA-Cide receives orphan drug designation

Treatment recommendations for generalized convulsive status epilepticus emerge from VA study

Rituximab now available in Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...